The 2-day conference gathers Researchers , academia, labs, Drug Manufacturers , government agencies, health professionals, hospitals, young investigators, Pharma and labs and presents their opinions through key notes, and case study presentations. This conference lays a platform for all the researchers working in the field of Antibiotics to know the latest developments and the current situation of the Antibiotic resistance problem.

Antibiotics 2021 is a platform to discuss and learn about the latest advancements in the field of Antibiotics and Antibiotic Resistance as the world’s consideration turned regarding the urgency of new antibiotics as the antimicrobial resistance is growing day by day. Many developed nations and International health organizations are trying to focus of the current situation and making new policies to prevent the adverse effects of Antibiotic resistance.

Antibiotics 2021 is intended to honour prestigious award for talented Young researchers, Scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, junior faculty in recognition of their outstanding contribution towards the conference theme. The Young Scientist Awards make every effort in providing a strong professional development opportunity for early career academicians by meeting experts to exchange and share their experiences on all aspects of Pharmacology.

We organize a series of 3000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members .

Antibiotics 2021 invites all the participants from all over the world to attend “8 th World Congress and Exhibition on Antibiotics and Antibiotic Resistance” to be held on March 08-09, 2021 | Rome, Italy which includes prompt Keynote presentations , Oral talks , Poster presentations and Exhibitions .

Scientific Session/Tracks

After a successful conference of Antibiotics 2020, we are currently bringing forth “8th World Congress and Exhibition on Antibiotics and Antibiotic Resistance” (Antibiotics 2020) slated on March 08-09, 2021 at Rome, Italy. Antibiotics 2021 aims to gather attendees, participants, students, and speakers, organizing committee members, delegates, most elegant societies and industries, renowned and honourable persons from top universities across the globe to London, UK. We are delighted to invite you to our 8th World Congress and Exhibition on Antibiotics and Antibiotic Resistance on March 08-09, 2021 at Rome, Italy.

Antibiotics 2021 covers various aspects of Antibiotics, Antimicrobial Therapy, Antimicrobial Peptides, Antibiotics for Emerging & Re-Emerging Diseases, Drug Discovery Technologies in Antibiotics, Antibiotic production and Delivery method, Microorganisms Producing Antibiotics, Applications of Antibiotics, Pharmacokinetics and Pharmacodynamics of Antimicrobial drugs, Veterinary Importance of Antibiotics, Antibiotics for Oncology, Antibiotics Overuse and Resistance, Antibiotic-resistant Bacterial infections, Mechanism and Evolution of Antibiotic Resistance, Genetics of Antibiotic Resistance, Clinical Trials of Antibiotics, Clinical and Economic Burden of Antibiotic Resistance, Antibiotics: Market Analysis & Business Opportunities, Prevention and Control of Antibiotic resistance, New antibiotics and non-antibiotic approaches, Current research in antibiotic resistance, The Next Generation Approach of Antibiotics, Developing Alternatives to Antibiotics.

Track 1: ANTIBIOTICS

Antibiotics are a type of antimicrobials used in treatment and prevention of bacterial infections. They may inhibit or kill the growth of bacteria. Many antibiotics are also effective against protozoans and fungi; some are toxic to animals and humans also, even when given in therapeutic dosage. Antibiotics are not effective against viruses such as influenza or common cold, and may be harmful when taken inappropriately. Physicians must ensure the patient has a bacterial infection before prescribing antibiotics.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 2: ANTIMICROBIAL THERAPY

An antimicrobial therapy kills or inhibits the growth of microorganisms such as bacteria, fungi, or protozoans. Antimicrobial agents are some of the most widely, and often used therapeutic drugs worldwide. It contributes significantly to the quality of life of many people and reduces the morbidity and mortality due to infectious disease. The remarkable success of antimicrobial therapy has been achieved with comparatively little toxicity and expense.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 3: ANTIMICROBIAL PEPTIDES

Antimicrobial peptides (AMPs), also called Host Defence Peptides (HDPs) are part of the innate immune response found among all classes of life. AMPs have a broad spectrum of targeted organisms ranging from viruses to parasites. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as Immunomodulatory.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 4: ANTIBIOTICS FOR EMERGING & RE-EMERGING DISEASES

Antimicrobial agents play vital roles in decreasing human morbidity and mortality resulting from infectious diseases. Emerging and re-emerging infectious diseases are global problems, and a constant supply of new antibiotics is essential if we are to combat these diseases successfully. The session is open to discuss on synthetic tailoring, discovery of new scaffolds, designing screens that avoid rediscovering old scaffolds, repurposing libraries of synthetic molecules for use as antibiotics, Exploring microbial niches for products, molecular target selection, improving libraries to overcome resistance, Safety and efficacy, Vaccines available for the diseases, Phage’s and parasitic bacteria, Epidemiology and spread of microbes and resistance traits.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 5: DRUG DISCOVERY TECHNOLOGIES IN ANTIBIOTICS

Infectious diseases account for nearly one fifth of the worldwide death toll every year. The constant increase of drug‐resistant pathogens is a big challenge for treatment of infectious diseases. In addition, outbreaks of infections and new pathogens are potential threats to public health. Lack of effective treatments for drug‐resistant bacteria and recent outbreaks of Ebola and Zika viral infections have become a global public health concern. The number of newly approved antibiotics has decreased significantly in the last two decades compared with previous decades. In parallel with this, is an increase in the number of drug‐resistant bacteria. For these threats and challenges to be countered, new strategies and technology platforms are critically needed. Drug remodelling has emerged as an approach for rapid identification of effective therapeutics to treat the infectious diseases.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 6: ANTIBIOTIC PRODUCTION AND DELIVERY METHOD

Antibiotic production can be grouped into three methods: natural fermentation, semi-synthetic, and synthetic. As more and more bacteria continue to develop resistance to currently produced antibiotics, research and development of new antibiotics continues to be important. In addition to research and development into the production of new antibiotics, repackaging delivery systems is important to improving efficacy of the antibiotics that are currently produced. Improvements to this field have seen the ability to add antibiotics directly into implanted devices, aerosolization of antibiotics for direct delivery, and combination of antibiotics with non-antibiotics to improve outcomes.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 7: MICROORGANISMS PRODUCING ANTIBIOTICS

Antibiotic is one of the most important commercially exploited secondary metabolites produced by bacteria, fungi and Streptomyces and employed in a wide range. Most of the antibiotics used today are from the microorganisms that live in soil. Bacteria are easy to isolate, culture, maintain and to improve their strain. The main producers of the microbial metabolites, the actinobacteria, fungi and other filamentous bacteria, represent inexhaustible sources for the future.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 8: APPLICATIONS OF ANTIBIOTICS

Antibiotics are used commercially, potentially useful in medicine for activities other than their antimicrobial action. They are used as antitumor agents, enzyme inhibitors including powerful hypocholesterolemic agents, immunosuppressive agents, and anti-migraine agents, etc. This session mainly is to focus on the application of anti-bacterials, antifungals, and anti-cancers with their clinical use to date, including the development history, side effects, and etc. The antibiotics were classified by their uses, structure types, and molecular mechanisms.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 9: PHARMACOKINETICS AND PHARMACODYNAMICS OF ANTIMICROBIAL DRUGS

The pharmacodynamics of an antimicrobial drug relates its pharmacokinetics to the time course of the antimicrobial effects at the site of the infection. Knowledge of the drug's antimicrobial pharmacodynamics effects provides a more rational basis for determination of optimal dosing regimens in terms of the dose and the dosing interval than do the minimal inhibitory concentrations (MICs) and minimal bactericidal concentrations (MBCs) determined in vitro. This session mainly focus on pharmacokinetics, antimicrobial pharmacodynamics, the effect of pharmacodynamics on the emergence of resistant bacterial subpopulations, and the development of pharmacodynamics breakpoints for use in the design of trials of these drugs and in the treatment of infected patients.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 10: VETERINARY IMPORTANCE OF ANTIBIOTICS

Antibiotics are used in livestock production for two basic reasons: disease treatment and disease prevention. Just like humans, animals are prone to bacterial infections. As in human medicine, antibiotics are used to effectively treat those infections. In livestock production, antibiotics can also be used to prevent disease. There are times in an animal’s life, such as weaning, where certain diseases can be very common. Antibiotics are sometimes used to prevent these diseases from becoming established in the first place.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 11: ANTIBIOTICS FOR ONCOLOGY

An antibiotic is a chemical made by a microbe that antagonizes the growth of other cells. They reduce the viability and clonal expansion of cancer stem cells is of broad importance, as cancer stem cells are increasingly accepted as a distinct cell type that gives rise to therapy resistance, tumour recurrence and distant metastasis. Therapeutic anticancer antibiotics have become an accepted treatment for certain types of cancer. These drugs bind specifically to primary and metastatic cancer cells to block cell growth, while limiting effects on surrounding healthy cells. Antibiotic medicines kill malignant cells by fragmenting the DNA in the cell nucleus and by oxidizing critical compounds which are necessary for the cell. Antibiotics are used against leukaemia, bladder cancer, testicular cancer, and sarcomas.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 12: ANTIBIOTICS OVERUSE AND RESISTANCE

Antibiotic overuse is when antibiotics are used when they're not needed. Antibiotics are one of the great advances in medicine. But overprescribing them has led to resistant bacteria (bacteria that are harder to treat). Some germs that were once very responsive to antibiotics have become more and more resistant. Antibiotic overuse is a key driver of antimicrobial resistance. Antibiotic resistance occurs when bacteria change in response to the use of these medicines. Antibiotic resistance occurs naturally, but misuse of antibiotics in humans and animals is accelerating the process. Antibiotic resistance leads to longer hospital stays, higher medical costs and increased mortality.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 13: ANTIBIOTIC-RESISTANT BACTERIAL INFECTIONS

Antibiotics have been used to treat people with infectious diseases caused by bacteria. However, certain antibiotics have been used so widely and for so long that some bacteria that cause disease have become resistant to them, making these treatments less effective. Antibiotic resistance occurs when the medication loses its ability to kill bacteria. As a result, the organisms continue to grow and cause infection, even in the presence of the antibiotic.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 14: MECHANISM AND EVOLUTION OF ANTIBIOTIC RESISTANCE

Antibiotics target essential cellular functions but bacteria can become resistant by acquiring either exogenous resistance genes or chromosomal mutations. Resistance mutations typically occur in genes encoding essential functions; these mutations are therefore generally detrimental in the absence of drugs. However, bacteria can reduce this handicap by acquiring additional mutations, known as compensatory mutations. Genetic interactions (epistasis) either with the background or between resistances (in multiresistant bacteria) dramatically affect the fitness cost of antibiotic resistance and its compensation, therefore shaping dissemination of antibiotic resistance mutations.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 15: GENETICS OF ANTIBIOTIC RESISTANCE

Acquired bacterial antibiotic resistance can result from the mutation of normal cellular genes, the acquisition of foreign resistance genes, or a combination of these two mechanisms. The most common resistance mechanisms employed by bacteria include enzymatic degradation or alteration of the antimicrobial, mutation in the antimicrobial target site, decreased cell wall permeability to antimicrobials, and active efflux of the antimicrobial across the cell membrane. The spread of mobile genetic elements such as plasmids, transposons, and integrons has greatly contributed to the rapid dissemination of antimicrobial resistance among several bacterial genera of human and veterinary importance.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 16: CLINICAL TRIALS OF ANTIBIOTICS

There has been an increasing use of antibiotics in all areas of medicine. Clinical trials to test antibiotics are normally of a less than satisfactory quality. The main objective of initial clinical trials, at least, is to provide the pharmaceutical company with sufficient information to persuade the regulatory authority that the drug is effective, safe and well produced.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 17: CLINICAL AND ECONOMIC BURDEN OF ANTIBIOTIC RESISTANCE

Knowledge of the clinical and economic impact of antimicrobial resistance is useful to influence programs and behaviour in healthcare facilities, to guide policy makers and funding agencies, to define the prognosis of individual patients and to stimulate interest in developing new antimicrobial agents and therapies. There are a variety of important issues that must be considered when designing or interpreting studies into the clinical and economic outcomes associated with antimicrobial resistance. One of the most misunderstood issues is how to measure cost appropriately. This session mainly focus on variety of important issues that must be considered when designing or interpreting studies of the clinical and economic outcomes associated with antimicrobial resistance.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 18: ANTIBIOTICS: MARKET ANALYSIS & BUSINESS OPPORTUNITIES

Antibiotic medicines are among the most prescribed courses worldwide, in fighting bacterial infections, primarily in outpatient settings. Pharmaceutical companies are actively developing analogues of existing antibiotic classes based on innovative approaches to fight bacterial infections. Key players operating in the global antibiotic market include Pfizer Inc., Astellas Pharma, Inc, Roche, Novartis AG, Bristol-Myers Squibb Co., Bayer HealthCare AG, Abbott Laboratories, MiddleBrook Pharmaceuticals, Takeda Pharmaceutical Company, Ltd., Daiichi Sankyo Company, Ltd., GlaxoSmithKline Plc, Eli Lilly and Co., and Kyorin Pharmaceutical Co., Ltd. The antibiotics market was valued at USD 39.8 billion in 2015 and is expected to witness a CAGR of 4.0% over the forecast period. Increasing efforts are being witnessed toward the development of advanced products.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 19: PREVENTION AND CONTROL OF ANTIBIOTIC RESISTANCE

Antimicrobial resistance is a complex problem with many diverse contributing factors. It is major cause of health concerns adding cost to oneself and to the community, directly or indirectly. Prevention is still the best tool to reduce the infection spread and thereby AMR. Along with rational use of existing antimicrobial drugs, development of new effective compounds and new diagnostic technology is the need. Joint efforts from patients, prescribers and individuals to international regulators and policy makers are needed to fight against the globally spreading antimicrobial resistance.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 20: NEW ANTIBIOTICS AND NON-ANTIBIOTIC APPROACHES

New antibiotics need to be developed, which doctors will be able to use when existing drugs no longer work. Non-antibiotic treatments can also reduce our dependence on antibiotics. The government encourages companies to develop new drugs and treatments. New technologies can also help prevent infections.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 21: CURRENT RESEARCH IN ANTIBIOTIC RESISTANCE

Antibiotic overuse and misuse has led to a growing number of bacteria in humans, animals and the environment that are resistant to life-saving antimicrobial therapies. Urgent action is needed to halt the development of resistance, and to accelerate new treatments for bacterial infection. Research includes epidemiology of both Gram-negative and Gram-positive infections, genetic mechanisms of resistance, evolution and transmission in the hospital setting, as well as the community, and antimicrobial stewardship.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 22: THE NEXT GENERATION APPROACH OF ANTIBIOTICS

As research into antibiotic resistance expands, it is important to adopt an explicitly proactive approach to antibiotic resistance identification and surveillance, as well as antibiotic therapy development. This proactive approach involves using a combination of functional metagenomics, next-generation sequencing and cutting-edge computational methods to monitor the evolution and dissemination of resistance before a given resistance determinant emerges in a pathogen or in the clinical setting, as well as proactively developing next-generation therapies that target these resistance determinants. Recent advances in the field highlight the promise that the next generation of resistome studies hold for characterizing and countering emerging resistance threats.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 23: DEVELOPING ALTERNATIVES TO ANTIBIOTICS

Alternatives to antibiotics are broadly defined as any substance that can be substituted for therapeutic drugs that are increasingly becoming ineffective against pathogenic bacteria due to antimicrobial resistance. Although antibiotics remain an essential tool for treating animal diseases on the farm, the availability of effective medical interventions to prevent and control animal diseases is one of the most significant challenges facing veterinary medicine in the 21st century. Phytochemicals as antibiotic alternatives to promote growth and enhance host health. Innovative drugs, chemicals, and enzymes within the animal production chain. Vaccines as alternatives to antibiotics for food producing animals. Also recent research provides numerous possibilities for the application nanomaterials in broad-spectrum eradication of pathogenic bacteria with many applications such as skin pathogen infection, implant sterilization, and wastewater treatment.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology.